文献速递肾小球疾病

机械敏感离子通道Piezo1促进狼疮性肾炎足细胞骨架重塑与蛋白尿发生

The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis.
PubMed 文献 · Kidney Int · 2024-07-29

该研究在人和小鼠狼疮性肾炎(LN)足细胞中均发现Piezo1显著上调。Piezo1拮抗剂GsMTx4可减轻MRL/lpr小鼠肾小球肾炎和肾小管间质损伤、改善肾功能、减少蛋白尿并减轻足突融合;足细胞特异性Piezo1敲除对pristane诱导LN模型的蛋白尿进展和足突融合有保护作用。机制上Piezo1经钙内流增强Rac1活性、增加活性paxillin,促进骨架重塑并降低足细胞运动能力,提示抑制Piezo1可能成为LN治疗新策略。

要点

  • 人和小鼠LN足细胞中Piezo1表达显著上调。
  • Piezo1拮抗剂GsMTx4可改善MRL/lpr小鼠肾功能并减少蛋白尿。
  • 足细胞特异性Piezo1敲除对LN模型蛋白尿和足突融合有保护作用。

核心结论

  • Piezo1参与LN中足细胞损伤和蛋白尿进展,靶向降低或抑制Piezo1可能成为治疗LN的新策略。

研究设计与样本

  • 研究对狼疮倾向MRL/lpr小鼠使用Piezo1激动剂和拮抗剂处理,并构建足细胞特异性Piezo1敲除小鼠模型,以pristane诱导的鼠LN模型验证Piezo1在足细胞损伤中的作用。

主要发现

  • 人和小鼠LN足细胞中Piezo1明显上调。
  • Piezo1拮抗剂GsMTx4显著减轻MRL/lpr小鼠肾小球肾炎和肾小管间质损伤、改善肾功能、减少蛋白尿并减轻足细胞足突融合。
  • 足细胞特异性Piezo1缺失对鼠LN模型蛋白尿进展和足细胞足突融合有保护作用。
  • Piezo1表达可被IL-6、TNF-α、IFN-γ、可溶性尿激酶纤溶酶原激活物受体及其自身激活上调。
  • Piezo1激活引起钙内流,增强Rac1活性并增加活性paxillin,促进骨架重塑并降低足细胞运动能力。

临床怎么用

  • 在LN中可关注足细胞Piezo1作为潜在治疗靶点,抑制Piezo1可能减轻足细胞损伤和蛋白尿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Piezo1 functions as a special transducer of mechanostress into electrochemical signals and is implicated in the pathogenesis of various diseases across different disciplines. However, whether Piezo1 contributes to the pathogenesis of lupus nephritis (LN) remains elusive. To study this, we applied an agonist and antagonist of Piezo1 to treat lupus-prone MRL/lpr mice. Additionally, a podocyte-specific Piezo1 knockout mouse model was also generated to substantiate the role of Piezo1 in podocyte injury induced by pristane, a murine model of LN. A marked upregulation of Piezo1 was found in podocytes in both human and murine LN. The Piezo1 antagonist, GsMTx4, significantly alleviated glomerulonephritis and tubulointerstitial damage, improved kidney function, decreased proteinuria, and mitigated podocyte foot process effacement in MRL/lpr mice. Moreover, podocyte-specific Piezo1 deletion showed protective effects on the progression of proteinuria and podocyte foot process effacement in the murine LN model. Mechanistically, Piezo1 expression was upregulated by inflammatory cytokines (IL-6, TNF-α and IFN-γ), soluble urokinase Plasminogen Activator Receptor and its own activation. Activation of Piezo1 elicited calcium influx, which subsequently enhanced Rac1 activity and increased active paxillin, thereby promoting cytoskeleton remodeling and decreasing podocyte motility. Thus, our work demonstrated that Piezo1 contributed to podocyte injury and proteinuria progression in LN. Hence, targeted therapy aimed at decreasing or inhibiting Piezo1 could represent a novel strategy to treat LN.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Fu R, Wang W, Huo Y, et al. The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis. Kidney Int. 2024. PMID: 39084260. doi:10.1016/j.kint.2024.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。